companies

Cibiltech

Founded 2019
Employees 30+
Primary contact
130 rue de Lourmel
75015 Paris
France
+33 (0)975 381261
Links
https://www.cibiltech.com/
Sections
Technologies
Cibiltech develops AI-based medical solutions to prevent organ failure. It uses predictive medicine to improve patients' quality of life and simplify healthcare systems and clinical data management. The company's iBox technology helps physicians monitor transplanted patients by providing allograft survival prognosis, while at the same time helping accelerate research and drug development (when it is used as an endpoint in clinical trials). Cibiltec also offers smart telemonitoring of chronic patients through its MyPredigraft platform, which acts as a medical hub for patients and their medical teams.
Select partners: Novartis, CareDx, Inserm, Université de Paris, Assistance publique Hôpitaux de Paris, Hospital del Mar, NHS, Fundación Puigvert, Tel Aviv Sourasky Medical Center, UZ Leuven.
Founded 2019
Employees 30+
Primary contact
130 rue de Lourmel
75015 Paris
France
+33 (0)975 381261
Links
https://www.cibiltech.com/
Sections
Technologies

Funding 💰

Select investors CareDx, EIT Health

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • Proven technology: The Paris Transplant Group developed the first universal predictive algorithm for transplantation in 2018 after 20 years of research. Cibiltech's iBox technology is based on the Paris Transplant Group's renowned scientific excellence and decades of experience caring for their own transplant patients. 🔗
  • CE mark: In June 2021, Cibiltech's Predigraft product received CE marking as a class IIa medical device under the new European MDR regulation -- allowing the company to offer it across the EU. 🔗
  • Expansion to America: In May 2019, the company has partnered with Brisbane, CA-based CareDx -- which has also acquired a minority equity ownership of Cibiltech -- to bring Predigraft to the United States. 🔗
  • Savvy founder: Stephane Tholander has both technical and business backgrounds. Also, Cibiltech is not the first company he founded.

Awards & Recognitions 🏆

  • 2021 Nobel project's Health Tech Award Finalist
  • 2019 Grands Prix de l'Innovation: Category winner (e-health)
Last update: August 17, 2022